HHGA
ALXN
Halbert Hargrove Global Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-1,200
| Closed | -$229K | – | 99 |
|
|
2015
Q4 | $229K | Buy |
+1,200
| New | +$229K | 0.1% | 88 |
|
|
2015
Q3 | – | Sell |
-2,518
| Closed | -$455K | – | 166 |
|
|
2015
Q2 | $455K | Buy |
2,518
+300
| +14% | +$54.2K | 0.11% | 97 |
|
|
2015
Q1 | $384K | Buy |
2,218
+673
| +44% | +$117K | 0.12% | 120 |
|
|
2014
Q4 | $286K | Sell |
1,545
-18
| -1% | -$3.33K | 0.14% | 94 |
|
|
2014
Q3 | $259K | Buy |
+1,563
| New | +$259K | 0.07% | 112 |
|
|
2014
Q2 | – | Sell |
-2,930
| Closed | -$446K | – | 143 |
|
|
2014
Q1 | $446K | Sell |
2,930
-361
| -11% | -$55K | 0.14% | 49 |
|
|
2013
Q4 | $437K | Sell |
3,291
-353
| -10% | -$46.9K | 0.14% | 51 |
|
|
2013
Q3 | $423K | Sell |
3,644
-252
| -6% | -$29.3K | 0.14% | 50 |
|
|
2013
Q2 | $359K | Buy |
+3,896
| New | +$359K | 0.13% | 64 |
|